Effect of Virtual Reality Headset Glasses Used in The Arteriovenous Fistule Cannulation Processon Paın and Patient Satisfaction
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Arteriovenous Fistula
- Sponsor
- Mersin University
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Pain evaluated using the Visual Analog Scale
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
This research was conducted as a randomized controlled experimental study aiming to determine the impact of virtual reality glasses used in the AVF process on the pain felt by patients and patient satisfaction.
Detailed Description
Chronic kidney disease (CKD) is a progressive, irreversible renal disease in which the ability of the body to maintain the balance of metabolism, fluid and electrolytes fails. Chronic kidney disease (CKD) is one of the major health problems with an increasing prevalence in the World. Hemodialysis as one of the most common methods of renal replacement therapy is a stressful procedure despite to maintain the survival of patients with chronic kidney disease that permanent and safe vascular access is one of the requirements of a successful hemodialysis. The pain of AVF puncture is common among the patients undergoing HD as acute and chronic pain which reported in more than 82% and 92% of them, respectively. Experience of the arteriovenous fistula puncture-related pain can have unpleasant effects on the patients, it causes that hemodialysis patients experience more disability, depression, irritability, and insomnia than other patients in adapting to stress. Experiencing continued pain can also affect the level of hemodialysis acceptance in patients and ultimately decrease quality of life. Therefore, pain control is an important priority in these patients.
Investigators
Didem Lafci
PhD
Mersin University
Eligibility Criteria
Inclusion Criteria
- •Receiving HD treatment
- •Open to communication
- •Fully oriented
- •Without vision, hearing and perception problems
- •Without any psychiatric illness
- •Without a history of seizures such as epilepsy
- •HD treatment administered via AVF
- •İn the last day, no injection was made into any artery or vein from the place where the intervention will be performed
- •Without any signs of infection such as redness, swelling, open wound in the area where the intervention will be performed
- •Standardized Mini Mental Test value is 24 points and above
Exclusion Criteria
- •Refusing to participate in the study
- •under the age of 18
- •Can't speak Turkish
- •Closed to communication and not fully oriented
- •Visual, hearing and perception problems
- •Any psychiatric illness
- •Having a history of seizures such as epilepsy
- •HD treatment not administered via AVF
- •Injection into any artery or vein from the place where the intervention will be performed in the last day,
- •Any signs of infection such as redness, swelling, open wound in the area to be operated
Outcomes
Primary Outcomes
Pain evaluated using the Visual Analog Scale
Time Frame: Change from before implementation, immediately after the procedure and after 10 minutes of practice (Virtual Reality Headset Glasses)
The patient marks a value between 1 and 10 on the Visual Analog Scale (VAS). As the value increases, the severity of pain increases.
Secondary Outcomes
- Blood pressure(Change from before implementation, immediately after the procedure and after 10 minutes of practice (Virtual Reality Headset Glasses))
- Heart rate(Change from before implementation, immediately after the procedure and after 10 minutes of practice (Virtual Reality Headset Glasses))
- respiratory rate(Change from before implementation, immediately after the procedure and after 10 minutes of practice (Virtual Reality Headset Glasses))
- peripheral oxygen saturation(Change from before implementation, immediately after the procedure and after 10 minutes of practice (Virtual Reality Headset Glasses))